ATLO vs BMY · P/E 15, rev $45.5M vs P/E 17, rev $24.46B
Ames National Corporation (ATLO) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Ames National Corporation (ATLO) is a banks - regional company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Latest reported ATLO revenue for 2026-06-30 was $45.5M. Net income was $11.9M. ATLO currently screens at market cap $165.7M and trailing P/E 14.6.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
ATLO currently screens at market cap $165.7M and trailing P/E 14.6. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the ATLO and BMY stock pages for the full models.
Not investment advice.